Deadline to Lead in Securities Class Action Against SelectQuote, Inc. (SLQT) is October 10, 2025 - Contact Kaplan FoxSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Deadline to Lead in Securities Class Action Against SelectQuote, Inc. (SLQT) is October 10, 2025 - Contact Kaplan FoxNEW YORK, NY - September 12, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) on behalf of investors that purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025 (the “Class Period”).
Faruqi & Faruqi Reminds SelectQuote Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 10, 2025 - SLQTFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SelectQuote To Contact Him Directly To Discuss Their Options
SELECTQUOTE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against SelectQuote, Inc. - SLQTNEW ORLEANS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Deadline Approaching for Investors of SelectQuote, Inc. (SLQT) - Contact Kaplan Fox Before October 10, 2025NEW YORK, NY - September 11, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) on behalf of investors that purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025 (the “Class Period”).
Deadline Approaching for Investors of SelectQuote, Inc. (SLQT) - Contact Kaplan Fox Before October 10, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Altimmune, Inc. (
NASDAQ:ALT), SelectQuote, Inc. (
NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (
NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SelectQuote, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLQTNEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Kaplan Fox Reminds Investors of a Securities Class Action Deadline Against SelectQuote, Inc. (SLQT) on October 10, 2025NEW YORK, NY - September 10, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) on behalf of investors that purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025 (the “Class Period”).
Kaplan Fox Reminds Investors of a Securities Class Action Deadline Against SelectQuote, Inc. (SLQT) on October 10, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
SELECTQUOTE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against SelectQuote, Inc. - SLQTNEW YORK and NEW ORLEANS , Sept. 09, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
SLQT INVESTORS: Kirby McInerney LLP Reminds SelectQuote, Inc. Investors of Important Deadline in Class Action Lawsuit
If you have suffered a loss on your SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE:SLQT) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
SELECTQUOTE, INC. (NYSE: SLQT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds SelectQuote, Inc. Investors of Upcoming DeadlineNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (
NYSE:NVO), Altimmune, Inc. (
NASDAQ:ALT), SelectQuote, Inc. (
NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (
NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Faruqi & Faruqi Reminds SelectQuote Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 10, 2025 - SLQTFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SelectQuote To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SelectQuote, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLQTNEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Lowey Dannenberg Notifies SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmNEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) for violations of the federal securities laws on behalf of investors who purchased or acquired SelectQuote securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”).
SELECTQUOTE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against SelectQuote, Inc. - SLQTNEW ORLEANS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuoteFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SelectQuote To Contact Him Directly To Discuss Their Options
Lowey Dannenberg Notifies SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmNEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) for violations of the federal securities laws on behalf of investors who purchased or acquired SelectQuote securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”).
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (
NYSE:NVO), Altimmune, Inc. (
NASDAQ:ALT), SelectQuote, Inc. (
NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (
NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SELECTQUOTE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against SelectQuote, Inc. - SLQTNEW YORK and NEW ORLEANS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
